A novel supramolecular block glycopolypeptide, designed to have the viral building blocks and be sensitive to CO 2, a physiological stimulus, was prepared via the orthogonal coupling of two end-functionalized biopolymers, dextran with β-cyclodextrin terminal (Dex-CD) and poly( l -valine) with a benzimidazole tail (BzI-PVal), respectively, driven by the end-to-end host–guest interactions. Due to the CO 2 -cleavable CD/BzI connection, both the vesicular and fibrous aggregates of this supramolecular block copolymer self-assembled in aqueous solution can undergo a reversible process of disassembly upon “breathing in” CO 2 and assembly upon “breathing out” CO 2, which mimics, to some extent, the disintegration and construction of viral capsid nanostructures.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: